Theratechnologies Inc. (NASDAQ:THTX) stock observed trading -66.25% off 52-week high price. On the other end, the stock has been noted 15.31% away from low price over the last 52-weeks. The stock disclosed a move of -14.03% away from 50 day moving average and -37.01% away from 200 day moving average. Moving closer, we can see that shares have been trading -10.93% off 20-day moving average. It has market cap of $185.46M.
On Feb. 25, 2020, Theratechnologies Inc. (NASDAQ:THTX) a commercial-stage biopharmaceutical company, notified its financial results for the year ended November 30, 2019.
Fiscal Year 2019 Financial Highlights
- Record revenue with net sales of US$63,216,000, up 39.8% from the previous year
- Trogarzo® sales reach US$27,696,000, up 212% from the previous year
- EGRIFTA® sales reach US$35,520,000, down 2.2% from the previous year
- Strong cash position of US$41,244,000
Our last fiscal year was one of many accomplishments. In the last twelve months, we managed to obtain approval for Trogarzo® in Europe, to launch a new formulation of tesamorelin, EGRIFTA SVTM, to list our shares on NASDAQ, to grow our revenues by 40 percent, to acquire a unique and highly-promising technology platform in oncology, to launch the development program of tesamorelin for the treatment of NASH in HIV and to manage to record a slightly positive EBITDA while investing in Europe and in our developments programs, said Luc Tanguay, President and CEO, Theratechnologies Inc.
We ended the year with a company stronger than ever and with tools to sustain growth through our commercialized products and a promising pipeline, added Mr. Tanguay.
The Canada based company Theratechnologies Inc. moved with change of 2.55% to $2.41 with the total traded volume of 69224 shares in recent session versus to an average volume of 106.64K. The stock was observed in the 5 days activity at -10.41%. The one month performance of stock was -14.23%. THTX’s shares are at -18.31% for the quarter and driving a -65.79% return over the course of the past year and is now at -26.97% since this point in 2018. The average volatility for the week and month was at 10.13% and 5.90% respectively. There are 76.95M shares outstanding and 76.95M shares are floated in market.
Christopher Pacheco has worked as financial analyst until his retirement. He is a well-known research director and portfolio manager for more than 5 years. After many years in the market, he dedicated all his time to write articles highlighting different financial problems.
Christopher Pacheco holds a postgraduate degree in Software Engineering from Canada. ‘The stock market is filled with individuals who know the price of everything, but the value of nothing.’ Christopher is a share market expert, being personally invested for over 6 years. He believes the most valuable nugget of wisdom for new investors is a quote from Phillip Fisher. He has been writing his entire life, and while he has made a career of business and finance reporting, he still enjoys writing short stories and poetry.
Address: 25176 10th Street, Greenfield, CA 93927, USA
Email: [email protected]
Zip code: 93927
Contact # 831-385-8150